Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-23

Clinical Trial Update: Pallidal Stimulation and Gilles de la Tourette Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating pallidal stimulation for Tourette syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Gilles de la Tourette Syndrome | Phase 3 | Status: COMPLETED